Esther Vicente Cemborain-rekin lankidetzan egindako argitalpenak (19)

2011

  1. Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis

    Infectious Disorders - Drug Targets, Vol. 11, Núm. 2, pp. 196-204

2010

  1. Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2- carbonitrile di-N-oxides

    Bioorganic and Medicinal Chemistry Letters, Vol. 20, Núm. 16, pp. 4831-4835

  2. Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR

    Chemical Biology and Drug Design, Vol. 76, Núm. 1, pp. 59-69

2009

  1. QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents

    Journal of Molecular Graphics and Modelling, Vol. 28, Núm. 1, pp. 28-36

  2. Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides

    Bioorganic and Medicinal Chemistry, Vol. 17, Núm. 1, pp. 385-389